| Literature DB >> 35711653 |
Weifa Su1,2,3,4, Tao Gong1,2,3,4, Zipeng Jiang1,2,3,4, Zeqing Lu1,2,3,4, Yizhen Wang1,2,3,4.
Abstract
Early weaning of piglets is an important strategy for improving the production efficiency of sows in modern intensive farming systems. However, due to multiple stressors such as physiological, environmental and social challenges, postweaning syndrome in piglets often occurs during early weaning period, and postweaning diarrhea (PWD) is a serious threat to piglet health, resulting in high mortality. Early weaning disrupts the intestinal barrier function of piglets, disturbs the homeostasis of gut microbiota, and destroys the intestinal chemical, mechanical and immunological barriers, which is one of the main causes of PWD in piglets. The traditional method of preventing PWD is to supplement piglet diet with antibiotics. However, the long-term overuse of antibiotics led to bacterial resistance, and antibiotics residues in animal products, threatening human health while causing dysbiosis of gut microbiota and superinfection of piglets. Antibiotic supplementation in livestock diets is prohibited in many countries and regions. Regarding this context, finding antibiotic alternatives to maintain piglet health at the critical weaning period becomes a real emergency. More and more studies showed that probiotics can prevent and treat PWD by regulating the intestinal barriers in recent years. Here, we review the research status of PWD-preventing and treating probiotics and discuss its potential mechanisms from the perspective of intestinal barriers (the intestinal microbial barrier, the intestinal chemical barrier, the intestinal mechanical barrier and the intestinal immunological barrier) in piglets.Entities:
Keywords: antibiotics; intestinal barriers; piglets; postweaning diarrhea; probiotics
Mesh:
Substances:
Year: 2022 PMID: 35711653 PMCID: PMC9197122 DOI: 10.3389/fcimb.2022.883107
Source DB: PubMed Journal: Front Cell Infect Microbiol ISSN: 2235-2988 Impact factor: 6.073
Effects of probiotics on treating PWD of piglet.
| Microorganism Category | Microorganism Name | Treatment | Host Health Influence | Reference |
|---|---|---|---|---|
| Lactic acid bacteria |
| Piglets weaned at 28 d of age were fed the basal diet mixed the probiotics (0.25 × 108 CFU/g for each strain) for 25 days, and orally administered with ETEC F18+ (2 × 109 CFU/g) on day 13 postweaning | Decreasing serum TNF-α; increasing jejunal villus height, and especially villus height-to-crypt depth ratio in piglets | ( |
|
| The piglets were orally administrated with | Increasing the height of intestinal villi of piglets; promoting the expression of intestinal TJs proteins, and reducing the incidence of diarrhea by more than 50% | ( | |
|
| Piglets weaned at 26 d of age were fed basal diet supplemented with |
| ( | |
|
| Piglets (4 d of age) were orally administrated with | Improving performance and effectively preventing the diarrhea; improving function of the intestinal barrier by protecting intestinal morphology and intestinal permeability and the expression of genes for TJs proteins | ( | |
|
| Piglets weaned at 28 d of age were fed corn-soybean meal mixed feed fermented by | Decreasing pro-inflammatory cytokine expression and alleviating | ( | |
| Yeast |
| Piglets weaned at 14 d b of age were fed basal diet supplemented with 3.0 g kg–1 live yeast | Decreasing numbers of | ( |
|
| Piglets weaned at 28 d of age were fed basal diet supplemented with 5 g/kg live yeast | Significantly lower daily diarrhea scores, duration of diarrhea, and shedding of pathogenic ETEC bacteria in feces and increasing IgA levels in the serum of piglets | ( | |
|
| Piglets weaned at 21 d of age were fed basal diet supplemented with |
| ( | |
|
| Piglets weaned at 26 d of age were fed basal diet supplemented with 200 g/t live | ADG increased by 39.9% and LPS-induced piglet mortality was reduced 20% | ( | |
|
| Piglets weaned at 21 d of age were fed | Increasing compensatory body weight gains after | ( | |
|
|
| Piglets weaned at 28 d of age were fed basal diet supplemented with 20 × 109 CFU/kg feed of |
| ( |
|
| Piglets (7.09 ± 0.2 kg) were fed basal diet supplemented with | Alleviating intestinal villi injury caused by ETEC F4 challenge | ( | |
| Three types of mixed bacteria |
| Piglet weaned at 28 d of age were fed the basal diet mixed the probiotics (>1 × 108 CFU/g for each strain) for 21days | Increasing fecal acetic acid and propionic acid; increasing growth performance and significantly reducing PWD | ( |
Effects of probiotics on immunity of piglets.
| Microorganism Category | Microorganism Name | Treatment | Host Health Influence | Reference |
|---|---|---|---|---|
| Lactic acid bacteria |
| Porcine intestinal epithelial were stimulated with | Improving IFN-β, IFN-λ and antiviral factors expression in PIE cells | ( |
|
| The piglets were orally administrated with | Increasing the concentration of IgG in serum; promoting the production of anti-inflammatory cytokines IL-4 and IL-10, and reducing the content of pro-inflammatory factor IL-1β | ( | |
|
| Piglets received a PBS suspension (2 mL, 108 CFU/mL) containing the | The level of serum IgG, intestinal sIgA, and IFN-γ were significantly increased | ( | |
| Lactobacillus reuteri | Intestinal porcine epithelial cells were treated with ETEC and Lactobacillus reuteri | Inhibited ETEC-induced expression of pro-inflammatory transcripts IL-6 and TNF-α and protein IL-6 and increased the level of the anti-inflammatory cytokine IL-10 | ( | |
|
| Piglets weaned at 25 d of age were fed basal diet supplemented with | The level of serum TNF-α was significantly increased | ( | |
| Yeast |
| Piglets (20 d of age) were fed with | Increasing the numbers of plasmocyte and lymphoid nodule; promoting the development of PPs and germinal center | ( |
| Brewery hydrolyzed yeast | Piglets weaned at 25 d of age were fed basal diet supplemented with 2 g/kg brewery hydrolyzed yeast for 28 days | Increased IgG and IgM antibodies in serum-binding KLH, and increased SRBC agglutination titers | ( | |
|
| Porcine small intestine epithelial cell was challenged | Decreased the mRNA ETEC-induced gene expression of pro-inflammatory cytokines TNF-α, IL-6, GM-CSF and chemokines CCL2, CCL20 and CXCL8 on intestinal IPI-2I | ( | |
|
| Porcine small intestine epithelial cell was challenged | Inhibited the ETEC-induced expression of pro-inflammatory transcripts IL-6, IL-8, CCL20, CXCL2, and CXCL10, as well as proteins IL-6 and IL-8 | ( | |
|
|
| Piglets (7.09 ± 0.2 kg) were fed basal diet supplemented with | Including myeloid differentiation factor, toll-interacting protein, and B cell CLL/lymphoma 3, in the intestines of ETEC F4-challenged piglets | ( |
|
| Piglets (14 d of age) were fed basal diet supplemented with | Reduced frequencies of CD8+ γδ T cells in the peripheral blood and the jejunal epithelium | ( | |
| Three types of mixed bacteria |
| Weaning pigs basal diet supplemented with 15% fermented soybean meal | The level of serum IgG, IgM and IgA were significantly increased, and autophagy factor LC3B in piglets showed a downward trend | ( |
Figure 1Modulation of probiotics on intestinal barriers in postweaning diarrhea piglets. Probiotics relieve PWD by regulating the intestinal microbial barrier: 1) shaping the gut microbiota oriented by beneficial bacteria; 2) competitive exclusion of pathogen; 3) producing antimicrobial substance and neutralize toxin. Probiotics relieve PWD by regulating the intestinal mucosal barrier: 1) stimulating the secretion of mucin and antimicrobial peptides; 2) upregulation of intestinal tight junction protein expression; 3) maintaining normal intestinal permeability, and promoting intestinal fluid absorption and secretion reduction. Probiotics relieve PWD by regulating the intestinal immunological barrier: 1) promoting the proliferation and differentiation of intestinal immune cell; 2) stimulating the secretion of inflammatory and SlgA. TLRs, Toll-like Receptors; MUC2, Mucin 2; TJs, Tight Junctions; DC, Dendritic Cell; TGF-β, Transforming growth factor-β; TNF, Tumor Necrosis Factor); IL, Interleukin; SIgA, Secretory Immunoglobulin A;AMPs, antimicrobial peptides.